Former Dendreon Corp. CEO Mitch Gold and investment analyst David Miller have teamed up to open a new Seattle-based hedge fund, Alpine BioVentures. The multimillion-dollar fund will invest in newer companies in the biotech space, particularly in the area of cancer and rare diseases.